NCT04893473

Brief Summary

This is a prospective, single arm, open, single centre clinical investigation designed to examine the feasibility and safety of the IscAlert™ device in patients scheduled for limb (arm/leg) surgery with tourniquet. IscAlert is measuring carbon dioxide in muscular and subcutaneous tissue. IscAlert is inserted into normal muscle and subcutaneous tissue in ischemic (operated limb with a tourniquet) and non-ischemic limb (non-operated limb).After the tourniquet is inflated, ischemia develops in the muscles and subcutaneous tissue. This will result in an increase in carbon dioxide, which will be detected by the sensor on the operated extremity, while the sensor on the non-operated will show normal values. After releasing the tourniquet cuff, the muscle will be reperfused and the carbon dioxide level is expected to decrease into normal levels. 50 number of patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the operating room, but in 25 of the patients, IscAlert™ will be inserted for 72 hours in the operated extremity after the end of surgery. After this, the sensors are removed.250 Devices is planned to be used in this clinical study.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

May 14, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
Last Updated

May 24, 2021

Status Verified

May 1, 2021

Enrollment Period

Same day

First QC Date

August 10, 2020

Last Update Submit

May 19, 2021

Conditions

Keywords

IschemiaCarbon dioxideBiosensorMusculatureSubcutaneousSurgeryOrthopedicLimb

Outcome Measures

Primary Outcomes (1)

  • Tissue carbon dioxide level

    Tissue carbon dioxide level (kPa) during insertion period

    72 hours

Secondary Outcomes (8)

  • Bleeding

    72 hours

  • Infection

    1 week

  • Arterial carbon dioxide level

    2 hours

  • Arterial lactate level

    2 hours

  • Arterial pH level

    2 hours

  • +3 more secondary outcomes

Study Arms (2)

Group 1

Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed immediately after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.

Device: IscAlert

Group 2

Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed 72 hours after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.

Device: IscAlert

Interventions

IscAlertDEVICE

3 IscAlert sensors in the limb undergoing surgery and two control sensors in the opposite limb are inserted and carbon dioxide is measured continuously.

Group 1Group 2

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who need limb surgery with tourniquet cuff

You may qualify if:

  • Patients must be scheduled for orthopedic limb surgery with planned use of tourniquet.
  • Subject must be ≥ 18 years
  • Able to give written signed informed consent
  • Tourniquet planned to be used \> 30 minutes

You may not qualify if:

  • Sign of inflammation/infection, hematoma, and traumatized tissue at insertion site
  • Chronic use of anticoagulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0424, Norway

Location

MeSH Terms

Conditions

Ischemia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Magne Røkkum, Md, Ph.d

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 10, 2020

First Posted

May 19, 2021

Study Start

May 14, 2021

Primary Completion

May 14, 2021

Study Completion

May 14, 2021

Last Updated

May 24, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

No plan to share IPD to other researchers

Locations